Global leaders across architecture, engineering, construction, consulting, and government contracting recognized for innovation using Deltek solutions

HERNDON, Va., Nov. 11, 2025 /PRNewswire/ — Deltek, the leading global provider of software and solutions for project-based businesses, today announced the winners of its annual Most Valuable Project (MVP) Awards at Deltek ProjectCon 2025, the company’s annual user conference. The Deltek MVP Awards honor the most innovative organizations among Deltek’s worldwide customers and partners across eight categories:

The Architecture and Engineering (A&E) Award

• Award Background: Recognizes an A&E firm utilizing Deltek Vantagepoint to successfully execute projects.
• Winner: Zutari is a leading buildings and infrastructure engineering and advisory practice with a proud legacy of over 90 years across Africa and the Middle East. The company partners with clients throughout the infrastructure lifecycle to deliver innovative, digitally enabled solutions across Buildings, Water Resources & Treatment, Mining & Industrial Infrastructure, Energy & Power, Transport & Mobility, Sustainability, and other sectors.
• Results: With Deltek partner Silversoft, Zutari implemented Deltek Vantagepont and:
  • Increased top-line growth by more than 20% with only an 8% increase in headcount.
  • Reduced project losses by nearly 50%.
  • Established a single, integrated ERP system to support real-time, data-driven decision-making.

The Consulting Award 

• Award Background: Recognizes a consulting firm using Deltek solutions as a key technology to deliver successful engagements to their clients.
• Winner:Omnicom Media Group India provides an Agency as a Platform (AaaP) approach by connecting best-in-class brands to demand capabilities that deliver better business outcomes for clients.
• Results: With Deltek Replicon’s Time Bill Plus, Time Off Plus and Time Attend Plus, Omnicom:
  • Reduced manual effort by 40%.
  • Increased compliance to 95%.
  • Real-time workforce visibility, fewer errors, and faster, data-driven decisions, boosting efficiency and scalability across the organization, and unifying operations for more than 500 users.

The Construction Award

• Award Background: Recognizes a construction firm utilizing Deltek ComputerEase to keep jobs on track.
• Winner:Gottstein Corporation is a leading industrial contractor serving the manufacturing industry with a primary focus on food and beverage production.
• Results: With Deltek ComputerEase, Gottstein Corporation has:
  • Scaled its growth for the past decade.
  • Doubled down on innovation in its goal to become a billion-dollar company.

The Enterprise Award

• Award Background: Recognizes a large business leveraging Deltek solutions to achieve a global mission.
• Winner:KPMG is a global organization of independent services firms providing Audit, Tax and Advisory services. Within the government and public sector, KPMG leverages its global experience to enhance digital footprints and promote sustainable practices in cities, defense, education, human and social services, and international development.
• Results: By migrating from Deltek Costpoint on-premise systems to Deltek Costpoint in the Cloud, KPMG:
  • Modernized its entire Deltek infrastructure – the backbone of KPMG’s Federal practice finance and accounting.
  • Eliminated 49 legacy servers, improved reporting performance and ensured compliance with federal audit requirements like DCAA and CMMC 2.0.
  • Supported over 2,300 employees for accurate billing, streamlined updates and long-term cost savings.

The Government Contracting Award

• Award Background: Recognizes a firm that is using Deltek solutions to successfully execute business with federal, state and local governments.
• Winner: Sierra Nevada Company (SNC) is a trusted global leader in aerospace and national security and its innovative solutions enable connected protection through command, control and communications systems.
• Results: SNC uses Deltek Costpoint, Cobra, PM Compass, and ProPricer on large multi-billion dollar programs across the portfolio to support: 
  • Timekeeping, inventory management, and BI reporting for over 4,500 employees.
  • Full EVM compliance, including Initial Baseline Reviews, Compliance Reviews, multiple IPMDAR deliveries, and data sets for seamless customer reporting.

The Partner Award

• Award Background: Recognizes a Deltek partner and customer that together have completed an exceptional implementation of a Deltek solution.
• Winner:Lexell Blue is a Deltek Premier Partner recognized for excellence in delivering transformative solutions. With deep expertise in mergers and acquisitions, data migration, manufacturing, integrations/extensibility, and full-scale implementation services across the Deltek Costpoint family of products, Lexell Blue brings unmatched knowledge and precision to every engagement.
• Results: In partnership with their enterprise client in the government contracting industry, Lexell Blue helped:
  • Reimplement Deltek Costpoint to modernize and consolidate legacy systems into one powerful ERP platform.
  • Reduce IT overhead, achieve 98% time entry adoption, and complete on-time financial close to support their 6,000 users.

The Professional Services Award

• Award Background: Recognizes a firm doing innovative work and succeeding with the help of Deltek solutions.
• Winner:IMEG Consultants Corp. is a leading U.S.-based engineering and consulting firm that delivers a rare combination — the broad expertise of a national leader with the personal relationships and deep collaboration of a local firm.
• Results: IMEG worked with strategic partner Baker Tilly on a unique solution related to FAR compliance within Deltek Vantagepoint, resulting in:
  • Transitioning 3,000 employees across more than 90 locations from a third-party expense platform to Deltek Vantagepoint Expense Reporting.
  • Lowering costs, enabling faster processing, and achieving smoother integration while maintaining FAR-compliant accounting of travel-related per diems.
  • Realizing a monetary return on investment and eliminating reliance on daily API transfers within four months.

The Small to Midsize Business Award

• Award Background: Recognizes a growing business doing innovative work and succeeding with the help of Deltek solutions.
• Winner:Adaptic LLC delivers innovative solutions in software development, systems engineering, analytics, and data science in support of the Intelligence Community.
• Results: Adaptic leveraged Deltek Costpoint and Deltek Dela’s AI-powered time entry integrated with Microsoft Teams to:
  • Empower its growth from one employee to 75 with minimal admin staff, while operating within secure SCIF environments.
  • Reduce accounting entry time by 75%.
  • Save 50% of time onboarding.
  • Improve business development tracking by 90%.

“On behalf of everyone here at Deltek, congratulations to all the MVP award winners. It’s an honor to stand with our customers and partners to help them achieve their mission-critical business goals,” said Margo Margo Martin, Chief Customer Officer at Deltek. “These winners are leaders in their industries, and we look forward to seeing how they grow in the years ahead.”

Learn how Deltek customers are powering project success.

About Deltek

Better software means better projects. Deltek is the leading global provider of enterprise software and information solutions for project-based businesses. More than 30,000 organizations and millions of users in over 80 countries around the world rely on Deltek for superior levels of project intelligence, management and collaboration. Our industry-focused expertise powers project success by helping firms achieve performance that maximizes productivity and revenue. Learn more at www.deltek.com.

Deltek Contact
Deltek Media Relations Team
press@Deltek.com

An integrated GPT-5 platform combining over 30 global AI models enables brands to create high-quality visuals and videos through natural conversation

TOKYO, Nov. 11, 2025 /PRNewswire/ — VCAT AI Corp., an AI-based marketing automation company, announced the official launch of CREAGEN, its innovative conversational AI solution for image and video generation.

CREAGEN integrates a GPT-5–powered conversational interface with more than 30 of the latest global AI generation models, including Kling, Sora, and Runway. The platform eliminates the need for complex prompts or multiple tools, allowing users to create brand-level visuals and videos simply by talking to AI.

Streamlining Creative Workflows with AI Conversation

Through the “Chat with AI” feature, CREAGEN enables anyone to generate high-quality content without specialized prompt skills. The AI interprets user intent and suggests tone, composition, and background—adapting results in real time to align with the brand’s identity.

By consolidating the generative AI workflow, CREAGEN helps companies overcome three common challenges in adopting generative AI:

1. Cost Reduction: One-stop integration of 30+ AI models reduces redundant subscription costs by up to 80%.
2. Professional Consistency: An end-to-end workflow allows anyone to produce expert-level visuals and videos with ease.
3. Brand Coherence: Custom preset systems trained on each company’s tone, color, and style ensure consistent visual quality across all campaigns.

“Enabling Brands to Create with Their Own Data and Identity”

“Many companies understand the importance of generative AI but struggle to implement it effectively. CREAGEN is designed to help them internalize AI-driven content production step by step—without the need for external specialists” said Beom-jin Jung, CEO of VCAT A.

“Our mission is to empower brands to produce content grounded in their unique data and identity. CREAGEN represents our vision of enabling every brand to become its own creative powerhouse.”

Expanding the Ecosystem: CREAGEN Lab

In addition to the self-service platform, VCAT AI also operates CREAGEN Lab, an AI-powered video production service that supports tailor-made creative projects by professional teams.

While CREAGEN allows companies to directly generate AI content, CREAGEN Lab offers a fully managed production option—providing strategic and creative support for marketing campaigns.

This dual-service approach has already been adopted by major brands including Lotte, Samsung Electronics, and LG Household & Health Care, with successful production of TV commercial–style campaign videos and branded content.

Through both services, VCAT AI supports companies in building in-house generative AI capabilities, establishing itself not only as a service provider but as a strategic partner helping brands integrate AI into their creative operations.

SINGAPORE, Nov. 11, 2025 /PRNewswire/ — Finmo today announced the launch of its new brand identity and positioning centred on Connected Financial Intelligence and Control for the Modern CFO. The refreshed brand marks Finmo’s evolution into a comprehensive Treasury Management System (TMS) – a unified platform that connects a company’s global financial infrastructure, powering real-time cash visibility, seamless money movement, and intelligent treasury automation.

David Hanna, Chief Executive Officer and Co-Founder at Finmo said: “For today’s CFO, finance is all about insight and foresight – anticipating challenges and responding with confidence. With Finmo’s platform, we give finance leaders a powerful “second sight”; the clarity to forecast outcomes, navigate uncertainty, and command greater strategic influence.

At the heart of Finmo’s evolution is its 4Cs framework – Connect, Control, Command, and Create – the foundation of a modern, connected treasury. By unifying these pillars together into one intelligent platform, Finmo gives finance teams a unified view of their entire financial landscape, sharper forecasting accuracy, and the agility to optimise liquidity and working capital in real time.

Mansi Chopra, Chief Marketing Officer at Finmo, said: “CFO expectations have evolved. In a world that moves fast, they want to complete their morning review in moments, with the intelligence, integration, and instant visibility to manage everything and see their entire treasury in one place. Our rebrand reflects that shift. Finmo gives CFOs instant visibility, automated control, and intelligent execution – turning the daily treasury review from hours into moments. Because in finance, control begins with clarity, and you can’t manage what you can’t see.”

Finmo’s platform brings this vision to life by unifying banks, ERPs, accounting systems, and payment gateways in one secure environment. Finance teams gain real-time cash and liquidity visibility, automated reconciliation, scalable cross-border payments, and proactive FX management – all in one place. The result: a smarter, connected treasury that doesn’t just track financial activity – it drives it.

About Finmo 

Finmo is a global fintech company transforming how modern finance teams manage cash and treasury operations.

Founded by David Hanna, Akhil Nigam, Richard Oh, Raj Vimal Chopra, and Thomas Kang, Finmo is purpose-built for today’s cross-border businesses. Our Treasury Management System delivers connected financial intelligence by bringing together data from bank accounts, accounting platforms, ERP systems, and other financial tools, giving CFOs real-time visibility, control, and foresight.

Beyond insights, Finmo empowers action. Through our global payments network and cash management offerings, finance teams can move money, optimize liquidity, and manage FX risk, all within a single intelligent platform. The result: businesses act faster, scale smarter, and operate with confidence in an increasingly interconnected economy.

Trusted by leading enterprises and fintechs, Finmo is licensed in key markets including Singapore, Australia, New Zealand, Canada, the U.S. and the UK. We are committed to building a faster, smarter, and more resilient financial infrastructure for the digital economy.

For more details, visit: https://finmo.net

Media Contact
Sylvia McKaige, Salween Group, Finmo@salweengroup.com

• Top 3 industry verticals fueling Singapore’s cross-border growth are gaming, beauty, and fashion, which generated over US$1.6B¹ in transaction value.
• Beyond the U.S., Singapore businesses are capturing new consumer demand in Mexico, where shoppers are turning to Singapore for beauty and fashion products.

SINGAPORE, Nov. 11, 2025 /PRNewswire/ — More than 90,000 Singapore-based businesses are selling internationally with PayPal. This represents one in four of Singapore’s 356,100² registered businesses, underscoring how digital commerce is powering global reach for local businesses. Collectively, over 14 million global customers shopped from businesses in Singapore using PayPal.

Singapore Businesses Go Global: One in Four Sell Internationally with PayPal (PRNewsFoto/PayPal)

The latest insights, based on a year of PayPal global cross-border transaction data ³, spotlights Singapore as a rising force in global digital commerce. With more than 60 million cross-border transactions processed during the period, the findings highlight the resilience and international relevance of Singapore businesses, particularly in high-growth verticals such as gaming, fashion, beauty, digital goods, and software.

“PayPal continues to be a trusted partner for Singapore businesses expanding globally. Our brand gives international shoppers the confidence to buy across borders, and today, one in four local businesses sell internationally with PayPal. With our secure digital payment solutions and infrastructure, even the smallest business can reach customers around the world. For example, Singapore brands are gaining traction in high-growth markets such as Mexico, particularly in the beauty and fashion sectors. With product offerings like PayPal Ads and PayPal Rewards now available in selected international markets, we’re helping local businesses grow their global customer base and build resilience in today’s dynamic trade environment. We look forward to introducing even more solutions in 2026 to further simplify international expansion for businesses,” said Matthew Lucas, Vice President and Head of Cross Border Trade at PayPal.

Top 3 Verticals with the Highest Annual Transaction Value: Gaming, Beauty, and Fashion
Singapore’s cross-border growth is being driven by three key sectors – gaming, beauty, and fashion – which together generated more than US $1.6 billion in transaction value. Gaming emerged as Singapore’s most shopped cross-border category, generating more than US$593 million in transaction value and averaging 1.7 million transactions each month. The United States (U.S.) led as the top country buying from Singapore businesses with more than 500,000 monthly purchases, followed by Germany (230,000+), Japan (175,000+), the United Kingdom (100,000+), and France (84,000+), pointing to strong demand across developed economies.

Beauty, Singapore’s second strongest lifestyle export, generated over US$411 million in transaction value and averaged 898,000 monthly transactions. Demand was concentrated in emerging trade corridors such as Mexico with over 297,000 monthly purchases, followed by the United States (25,000+), Australia (21,000+), and China (16,000+). This mix shows the global appeal of Singapore’s beauty and wellness brands, resonating well outside Asia in both niche and competitive markets.

Fashion exports reached more than US$636 million in transaction value, averaging 737,000 monthly transactions. Demand was led by the United States (230,000+ monthly purchases), Mexico (194,000+), Japan (118,000+), and Germany (18,000+). From independent labels to established names, Singapore’s fashion sector is finding loyal followings abroad across both developed economies and fast-growing corridors.

In addition to these leading lifestyle exports, Singapore businesses are also building scale in digital goods, and in computers & software. Digital goods, spanning in-app purchases, subscriptions, and digital content, generated over US$276 million in transaction value with 665,000 monthly transactions on average, led by demand from the United States (254,000+ monthly purchases), Germany (92,000+) and Canada (34,000+). Together, these figures highlight the scalability of Singapore businesses and the critical role of trusted payment infrastructure in enabling their international growth.

Diversification Beyond Traditional Corridors
While the United States remains Singapore’s largest corridor, accounting for more than US$830 million in purchases, the latest insights show that Singapore businesses are increasingly tapping into new growth beyond traditional markets. Mexico has emerged as a fast-growing destination, with more than 7 million purchases worth over US$370 million, primarily in fashion and beauty.

Methodology
The insights in PayPal Global Beat 2025 are based on internal PayPal cross-border transaction data from April 1, 2024, to March 31, 2025. It examines trade flows from Singapore to international markets, analyzing transaction volumes and values across top verticals and buyer corridors. Discover more insights from PayPal Global Beat 2025 here.

About PayPal
PayPal has been revolutionizing commerce globally for more than 25 years. Creating innovative experiences that make moving money, selling, and shopping simple, personalized, and secure, PayPal empowers consumers and businesses in approximately 200 markets to join and thrive in the global economy. For more information, visit https://www.paypal.com, https://about.pypl.com, and https://investor.pypl.com.

Media contacts:
Prisita Menon
primenon@paypal.com

Edelman for PayPal
PayPalSGTeam@edelman.com

• Following the group restructuring, Onward Therapeutics, Inc. serves as the global headquarters and holding company in Taiwan.
• The existing Swiss and French subsidiaries maintain fully operational, focusing on preclinical and clinical development.
• All licenses, IP rights, and ongoing R&D projects remain unchanged.

TAIPEI and LAUSANNE, Switzerland, Nov. 11, 2025 /PRNewswire/ — Onward Therapeutics today announced the completion of a share exchange, under which Onward Therapeutics, Inc. (Onward Taiwan) has become the group’s global holding and headquarters, while Onward Therapeutics SA (Onward Switzerland) has become a wholly owned subsidiary of Onward Taiwan.

The group reorganization involved the exchange of all shares in the former Swiss parent company for shares in the new Taiwan entity, maintaining ownership ratios and board composition. This milestone marks a strategic step in aligning Onward’s global operations and expanding its presence across Asia and Europe. The Taiwan entity brings together Onward’s scientific and corporate teams across Taiwan, Switzerland, and France under a unified corporate structure.

Over the past six years, Onward has built a robust pipeline of four innovative programs targeting both solid and hematologic tumors, through in-licensing, acquisition, and internal discovery. The group reorganization was designed to align Onward’s corporate structure with Taiwan’s dynamic biotechnology capital market and to support the company’s long-term growth plans, including future fundraising and potential public listing.

Building on its strong base of Taiwanese and multinational shareholders, Onward aims to leverage Taiwan’s scientific excellence, robust clinical trial infrastructure, and proven capabilities in advanced biopharmaceutical manufacturing to accelerate global development programs and partnerships. Taiwan’s supportive regulatory framework and innovation-driven investment environment further reinforce Onward’s ability to pursue sustainable growth and its role as an international enterprise.

Dr. C. Grace Yeh, Founder, Chairperson and CEO of Onward Therapeutics, stated “I am very grateful for the unanimous approval of the share exchange by all shareholders. Establishing our global headquarters in Taiwan represents both a symbolic and pragmatic achievement for Onward. Taiwan combines innovation, efficiency, and connectivity, the essential elements for the next stage of our global growth. With an outstanding scientific community and a strong investor base, Taiwan provides the ideal environment for Onward to expand its mission of developing transformative cancer therapies worldwide.”

About Onward Therapeutics

Onward Therapeutics (www.onward-therapeutics.com) is a clinical-stage biotechnology company dedicated to overcoming cancer resistance with novel and multi-modality therapies. Led by a seasoned team in translational science and drug development, the company advances promising candidates through a fast-track development model. Its portfolio includes a bispecific antibody (OT-A201) licensed from Biomunex Pharmaceuticals, alongside an equity investment, and an allogeneic NK cell therapy (OT-C001) developed via its majority-owned subsidiary, Emercell. Beyond these two lead clinical assets, the company is developing two first-in-class early development programs, including a small molecule in onco-metabolism (OT-S00X) licensed from Institut du Cancer de Montpellier, and an internal multi-specific antibody platform (OT-A30X). Founded in Switzerland, the company has established its global headquarters in Taiwan, reinforcing its integrated global operation across Taiwan, Switzerland, and France.

• Following the group restructuring, Onward Therapeutics, Inc. serves as the global headquarters and holding company in Taiwan.
• The existing Swiss and French subsidiaries maintain fully operational, focusing on preclinical and clinical development.
• All licenses, IP rights, and ongoing R&D projects remain unchanged.

TAIPEI and LAUSANNE, Switzerland, Nov. 11, 2025 /PRNewswire/ — Onward Therapeutics today announced the completion of a share exchange, under which Onward Therapeutics, Inc. (Onward Taiwan) has become the group’s global holding and headquarters, while Onward Therapeutics SA (Onward Switzerland) has become a wholly owned subsidiary of Onward Taiwan.

The group reorganization involved the exchange of all shares in the former Swiss parent company for shares in the new Taiwan entity, maintaining ownership ratios and board composition. This milestone marks a strategic step in aligning Onward’s global operations and expanding its presence across Asia and Europe. The Taiwan entity brings together Onward’s scientific and corporate teams across Taiwan, Switzerland, and France under a unified corporate structure.

Over the past six years, Onward has built a robust pipeline of four innovative programs targeting both solid and hematologic tumors, through in-licensing, acquisition, and internal discovery. The group reorganization was designed to align Onward’s corporate structure with Taiwan’s dynamic biotechnology capital market and to support the company’s long-term growth plans, including future fundraising and potential public listing.

Building on its strong base of Taiwanese and international long-term shareholders, Onward aims to leverage Taiwan’s scientific excellence, robust clinical trial infrastructure, and proven capabilities in advanced biopharmaceutical manufacturing to accelerate global development programs and partnerships. Taiwan’s supportive regulatory framework and innovation-driven investment environment further reinforce Onward’s ability to pursue sustainable growth and its role as a globally oriented enterprise.

Dr. C. Grace Yeh, Founder, Chairperson and CEO of Onward Therapeutics, stated “I am very grateful for the unanimous approval of the share exchange by all shareholders. Establishing our global headquarters in Taiwan represents both a symbolic and pragmatic achievement for Onward. Taiwan combines innovation, efficiency, and connectivity, the essential elements for the next stage of our global growth. With an outstanding scientific community and a strong investor base, Taiwan provides the ideal environment for Onward to expand its mission of developing transformative cancer therapies worldwide.”

About Onward Therapeutics

Onward Therapeutics (www.onward-therapeutics.com) is a clinical-stage biotechnology company dedicated to overcoming cancer resistance with novel and multi-modality therapies. Led by a seasoned team in translational science and drug development, the company advances promising candidates through a fast-track development model. Its portfolio includes a bispecific antibody (OT-A201) licensed from Biomunex Pharmaceuticals, alongside an equity investment, and an allogeneic NK cell therapy (OT-C001) developed via its majority-owned subsidiary, Emercell. Beyond these two lead clinical assets, the company is developing two first-in-class early development programs, including a small molecule in onco-metabolism (OT-S00X) licensed from Institut du Cancer de Montpellier, and an internal multi-specific antibody platform (OT-A30X). Founded in Switzerland, the company has established its global headquarters in Taiwan, reinforcing its integrated global operation across Taiwan, Switzerland, and France.